QT prolongation and sudden cardiac death risk in hypertrophic cardiomyopathy

Salma I Patel1, Michael J Ackerman2, Fadi E Shamoun3

  • 1a Center for Sleep Medicine , Mayo Clinic , Rochester , MN , USA.

Acta Cardiologica
|March 8, 2018
PubMed

Insights

Sudden cardiac death (SCD) risk in hypertrophic cardiomyopathy (HCM) is complex. Prolonged QTc interval on ECG is a significant predictor of SCD and death, even with other risk factors present.

Area of Science:

  • Cardiology
  • Clinical Electrophysiology
  • Cardiovascular Research

Background:

  • Sudden cardiac death (SCD) risk stratification in hypertrophic cardiomyopathy (HCM) is challenging.
  • Electrocardiogram (ECG)-derived markers are crucial for assessing SCD risk in HCM patients.

Purpose of the Study:

  • To evaluate ECG-derived risk factors for SCD in a large cohort of HCM patients.
  • To determine the predictive value of the QTc interval for SCD and mortality in HCM.

Main Methods:

  • Retrospective review of 1615 adult HCM patients evaluated at Mayo Clinic (2002-2012).
  • Analysis of ECG and 24-hour Holter monitor data.
  • Logistic regression models used to assess risk factors for SCD, including conventional factors and QTc interval.

Main Results:

  • Increasing numbers of conventional risk factors significantly elevated SCD odds (OR 4.88 for 1, 6.92 for 2, 13.99 for 3+).
  • A QTc interval > 450 ms was an independent predictor of SCD (OR 1.72) and death (HR 1.88).
  • No correlation found between SCD and other ECG findings like arrhythmias or conduction blocks.

Conclusions:

  • Prolonged QTc interval is a significant risk factor for SCD and mortality in HCM patients.
  • ECG assessment, particularly QTc duration, aids in refining SCD risk prediction in HCM.
  • QTc interval should be considered alongside conventional risk factors for comprehensive SCD risk assessment in HCM.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
530
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
591
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
593
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
470
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
620
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
367